- Home
- DSM vs TERN Comparison
DSM vs TERN Comparison
Compare DSM & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- TERN
- Stock Information
- Founded
- DSM 1989
- TERN 2017
- Country
- DSM United States
- TERN United States
- Employees
- DSM N/A
- TERN N/A
- Industry
- DSM Investment Managers
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- DSM Finance
- TERN Health Care
- Exchange
- DSM Nasdaq
- TERN Nasdaq
- Market Cap
- DSM 270.9M
- TERN 263.8M
- IPO Year
- DSM N/A
- TERN 2021
- Fundamental
- Price
- DSM $5.55
- TERN $3.28
- Analyst Decision
- DSM
- TERN Buy
- Analyst Count
- DSM 0
- TERN 5
- Target Price
- DSM N/A
- TERN $15.63
- AVG Volume (30 Days)
- DSM 161.7K
- TERN 687.9K
- Earning Date
- DSM 01-01-0001
- TERN 05-08-2025
- Dividend Yield
- DSM 3.97%
- TERN N/A
- EPS Growth
- DSM N/A
- TERN N/A
- EPS
- DSM N/A
- TERN N/A
- Revenue
- DSM N/A
- TERN N/A
- Revenue This Year
- DSM N/A
- TERN N/A
- Revenue Next Year
- DSM N/A
- TERN N/A
- P/E Ratio
- DSM N/A
- TERN N/A
- Revenue Growth
- DSM N/A
- TERN N/A
- 52 Week Low
- DSM $4.69
- TERN $1.87
- 52 Week High
- DSM $6.05
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- DSM 40.81
- TERN 60.54
- Support Level
- DSM $5.55
- TERN $3.01
- Resistance Level
- DSM $5.61
- TERN $3.17
- Average True Range (ATR)
- DSM 0.06
- TERN 0.18
- MACD
- DSM -0.02
- TERN 0.02
- Stochastic Oscillator
- DSM 10.00
- TERN 91.35
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.